Listen Now

Topics Covered

  • Overview of Clinical Trials
  • Why They Are Important for Blood Cancers
  • Clinical Trials in the US & Internationally
  • How Clinical Trials Contribute to Treatment Options
  • Participation in Clinical Trials
  • The Clinical Trial Health Care Team
  • What Happens in a Clinical Trial
  • The Meaning of Informed Consent
  • Benefits & Risks of Participation
  • Where Are Clinical Trials Conducted
  • Specific Questions to Ask Your Health Care Team
  • How to Find Blood Cancer Trials
  • Discussing Your Concerns with the Clinical Trial Team
  • Questions for Our Panel of Experts

Our Panel of Experts

William I. Bensinger, MD

Center for Blood Disorders and Stem Cell Transplantation, SCI’s Personalized Medicine Program, Myeloma & Transplant Program, Swedish Cancer Institute

Michael J. Mauro, MD

Leader, Myeloproliferative Neoplasms Program Member, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College

Krisstina L. Gowin, DO

Assistant Professor of Medicine, University of Arizona, Tucson, AZ, Research Collaborator, Mayo Clinic, Phoenix, AZ

Elizabeth K. O’Donnell, MD

Instructor, Harvard Medical School, Department of Hematology/Oncology, Massachusetts General Hospital Cancer Center

Elias Jabbour, MD

Associate Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW

Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop(pdf)(79.4 KB)

Workshop Date

This workshop was originally recorded on June 19, 2018.

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you will learn more about our use of cookies which help us make continuous improvements to our website. Learn more.